Savara Inc Unrealized Gain (Loss) on Investments
Savara Inc (SVRA) reported Unrealized Gain (Loss) on Investments of -$1.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2017-05-09
- Savara Inc unrealized gain (loss) on investments for the quarter ending 2017-03-31 was -$1.00K, a 104.55% decline year-over-year.
- Savara Inc unrealized gain (loss) on investments for the quarter ending 2016-12-31 was -$4.00K.
- Savara Inc unrealized gain (loss) on investments for the quarter ending 2016-09-30 was -$2.00K.
- Savara Inc unrealized gain (loss) on investments for the quarter ending 2016-06-30 was $2.00K, a 83.33% decline year-over-year.
- Savara Inc unrealized gain (loss) on investments for fiscal 2016 was $18.00K, a 125.00% increase from fiscal 2015.
- Savara Inc unrealized gain (loss) on investments for fiscal 2015 was $8.00K, a 100.00% increase from fiscal 2014.
- Savara Inc unrealized gain (loss) on investments for fiscal 2014 was $4.00K.
- Savara Inc unrealized gain (loss) on investments for fiscal 2013 was -$19.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 3 month as first filed | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 6 month as first filed | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 9 month as first filed | Unrealized Gain (Loss) on Investments 12 month | Unrealized Gain (Loss) on Investments 12 month as first filed | Unrealized Gain (Loss) on Investments 193 month | Unrealized Gain (Loss) on Investments 196 month | Unrealized Gain (Loss) on Investments 199 month | Unrealized Gain (Loss) on Investments 202 month | Unrealized Gain (Loss) on Investments 205 month | Unrealized Gain (Loss) on Investments 208 month | Unrealized Gain (Loss) on Investments 211 month | Unrealized Gain (Loss) on Investments 214 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | -$1.00K 10-Q · filed 2017-05-09 | -$5.00K derived: sum of 2 quarters · filed 2017-05-09 | -$7.00K derived: sum of 3 quarters · filed 2017-05-09 | -$5.00K derived: sum of 4 quarters · filed 2017-05-09 | ||||||||||||
| 2016-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$6.00K derived: sum of 2 quarters · filed 2017-03-06 | -$4.00K derived: sum of 3 quarters · filed 2017-03-06 | $18.00K 10-K · filed 2017-03-06 | ||||||||||||
| 2016-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $22.00K 10-Q · filed 2016-11-08 | -$4.00K derived: sum of 4 quarters · filed 2017-05-09 | ||||||||||||
| 2016-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $24.00K 10-Q · filed 2016-08-09 | -$2.00K derived: sum of 3 quarters · filed 2017-05-09 | -$3.00K derived: sum of 4 quarters · filed 2017-05-09 | ||||||||||||
| 2016-03-31 | $22.00K 10-Q · filed 2017-05-09 | -$4.00K derived: sum of 2 quarters · filed 2017-05-09 | -$5.00K derived: sum of 3 quarters · filed 2017-05-09 | $7.00K derived: sum of 4 quarters · filed 2017-05-09 | ||||||||||||
| 2015-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$27.00K derived: sum of 2 quarters · filed 2017-03-06 | -$15.00K derived: sum of 3 quarters · filed 2017-03-06 | $8.00K 10-K · filed 2017-03-06 | ||||||||||||
| 2015-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $11.00K derived: sum of 2 quarters · filed 2016-11-08 | $34.00K 10-Q · filed 2016-11-08 | $42.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||
| 2015-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $35.00K 10-Q · filed 2016-08-09 | $43.00K derived: sum of 3 quarters · filed 2017-03-06 | $36.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||
| 2015-03-31 | $23.00K 10-Q · filed 2016-05-06 | $31.00K derived: sum of 2 quarters · filed 2017-03-06 | $24.00K derived: sum of 3 quarters · filed 2017-03-06 | $32.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||
| 2014-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $1.00K derived: sum of 2 quarters · filed 2017-03-06 | $9.00K derived: sum of 3 quarters · filed 2017-03-06 | $4.00K 10-K · filed 2017-03-06 | -$4.00K 10-K · filed 2015-03-24 | |||||||||||
| 2014-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.00K derived: sum of 2 quarters · filed 2015-11-12 | -$4.00K 10-Q · filed 2015-11-12 | -$3.94K 10-Q · filed 2014-10-31 | $3.53K derived: sum of 4 quarters · filed 2015-11-12 | |||||||||||
| 2014-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $3.00K 10-Q · filed 2015-08-12 | $2.83K 10-Q · filed 2014-08-11 | $10.53K derived: sum of 3 quarters · filed 2015-08-12 | -$9.36K derived: sum of 4 quarters · filed 2015-08-12 | |||||||||||
| 2014-03-31 | -$5.00K 10-Q · filed 2015-05-11 | $5.45K 10-Q · filed 2014-05-05 | $2.53K derived: sum of 2 quarters · filed 2015-05-11 | -$17.36K derived: sum of 3 quarters · filed 2015-05-11 | -$15.55K derived: sum of 4 quarters · filed 2015-05-11 | $24.03K 10-Q · filed 2014-05-05 | ||||||||||
| 2013-12-31 | $7.53K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | -$12.36K derived: sum of 2 quarters · filed 2015-03-24 | -$10.55K derived: sum of 3 quarters · filed 2015-03-24 | -$19.00K 10-K · filed 2015-03-24 | $18.54K 10-K · filed 2014-03-26 | $18.58K 10-K · filed 2014-03-26 | ||||||||||
| 2013-09-30 | -$19.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | -$18.08K derived: sum of 2 quarters · filed 2014-10-31 | -$26.53K 10-Q · filed 2014-10-31 | $26.53K 10-Q · filed 2013-11-04 | -$26.55K derived: sum of 4 quarters · filed 2014-10-31 | $26.57K 10-Q · filed 2013-11-04 | ||||||||||
| 2013-06-30 | $1.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$6.64K 10-Q · filed 2014-08-11 | $6.64K 10-Q · filed 2013-08-05 | -$6.67K derived: sum of 3 quarters · filed 2014-08-11 | -$6.75K derived: sum of 4 quarters · filed 2014-08-11 | $6.68K 10-Q · filed 2013-08-05 | ||||||||||
| 2013-03-31 | -$8.45K 10-Q · filed 2014-05-05 | -$8.47K derived: sum of 2 quarters · filed 2014-05-05 | -$8.55K derived: sum of 3 quarters · filed 2014-05-05 | -$8.69K derived: sum of 4 quarters · filed 2014-05-05 | -$8.49K 10-Q · filed 2013-05-15 | |||||||||||
| 2012-12-31 | -$25.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$101.00 derived: sum of 2 quarters · filed 2014-03-26 | -$243.00 derived: sum of 3 quarters · filed 2014-03-26 | -$104.00 10-K · filed 2014-03-26 | $38.00 10-K · filed 2013-03-19 | |||||||||||
| 2012-09-30 | -$76.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | -$218.00 derived: sum of 2 quarters · filed 2013-11-04 | -$79.00 10-Q · filed 2013-11-04 | $88.00 derived: sum of 4 quarters · filed 2013-11-04 | $63.00 10-Q · filed 2012-11-05 | |||||||||||
| 2012-06-30 | -$142.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | -$3.00 10-Q · filed 2013-08-05 | $3.00 10-Q · filed 2012-08-06 | $164.00 derived: sum of 3 quarters · filed 2013-08-05 | -$139.00 10-Q · filed 2012-08-06 | |||||||||||
| 2012-03-31 | $139.00 10-Q · filed 2013-05-15 | $306.00 derived: sum of 2 quarters · filed 2013-05-15 | ||||||||||||||
| 2011-12-31 | $167.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-19 | $142.00 10-K · filed 2013-03-19 | ||||||||||||||
| 2011-09-30 | -$25.00 10-Q · filed 2012-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |